Top

Published in:

01-12-2016 | Original Article

Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment—a Pilot Study from Northern India

Authors: Abhishek Kumar Singh, Jitendra Kumar Kushwaha, Akshay Anand, Abhinav Arun Sonkar, Nuzhat Husain, Kirti Srivastava, Sudhir Singh

Published in: Indian Journal of Surgical Oncology | Issue 4/2016

Abstract

Human papilloma virus (HPV)-associated head and neck cancer (HNC) has generated significant amount of research interest in recent times with focus shifted to oral cavity squamous cell cancer (OCSCC) after oropharyngeal cancer. Due to high incidence of OCSCC and anecdotal reports on association of HPV infection from northern region of India, this study was conceived to investigate HPV infection and establish its association with lifestyle habits such as tobacco, alcohol consumption, oro-genital sex, number of sexual contacts, and change in quality of life posttreatment. A total of 43 primary OCSCC biopsy specimens were collected. These samples were analyzed for HPV DNA genotyping which was done by using 13 high-risk HPV real-time PCR kits. Quality of life was assessed using University of Washington questionnaire for HNC patients, which was administered pretreatment and 3-months posttreatment. HPV presence was confirmed in only three patients (7.0 %). HPV positivity did not find any statistical correlation with age, gender, residence, addiction habit, stage, tumor size, nodal status, tumor grade, and number of sexual contacts. There was no significant (p > 0.05) difference in the average percent change in QOL parameters from pretreatment to posttreatment when correlated with HPV status.

Coelho KR (2012) Challenges of the oral cancer burden in India. J Cancer Epidemiol 2012:701932CrossRefPubMedPubMedCentral

Sankaranarayanan R, Ramadas K, Thomas G et al (2005) Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365(9475):1927–1933CrossRefPubMed

IARC (2004) Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83:1–1438

IARC (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 89:1–592

IARC (1988) Alcohol drinking. Epidemiological studies of cancer in humans. IARC Monogr Eval Carcinog Risks Hum 44:153–250

Syrjanen K, Syrjanen S, Lamberg M et al (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12:418–424CrossRefPubMed

Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35CrossRefPubMedPubMedCentral

Syrjanen S, Lodi G, von Bultzingslowen I et al (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 17(Suppl 1):58–72CrossRefPubMed

Kreimer AR, Villa A, Nyitray AG et al (2011) The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomark Prev 20:172–182CrossRef

10.

Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M (2012) Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 6(Suppl 1):S104–S120CrossRefPubMed

11.

Gillison ML, Broutian T, Pickard RK et al (2012) Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 307:693–703CrossRefPubMed

12.

Pickard RK, Xiao W, Broutian TR et al (2012) The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 39:559–566CrossRefPubMed

13.

Bui TC, Markham CM, Ross MW, Mullen PD (2013) Examining the association between oral health and oral HPV infection. Cancer Prevent Res 6:917–924CrossRef

14.

Lang Kuhs KA, Gonzalez P, Struijk L et al (2013) Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis 208:1643–1652CrossRefPubMedPubMedCentral

15.

Kero K, Rautava J, Syrjanen K, Grenman S, Syrjanen S (2012) Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol 62:1063–1070CrossRefPubMed

16.

Kumar R, Rai AK, Das D et al (2015) Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: study from north-east region of India. PLoS One 10(10):e0140700CrossRefPubMedPubMedCentral

17.

Koppikar P, deVilliers EM, Mulherkar R (2005) Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 113(6):946–950CrossRefPubMed

18.

Mishra A, Bharti AC, Varghese P et al (2006) Differential expression and activation of NF-jB family proteins during oral carcinogenesis: role oh high risk human papilloma infection. Int J Cancer 119:2840–2850CrossRefPubMed

19.

Chaudhary AK, Pandya S, Singh M et al (2013) Identification of high-risk human papillomaviruse (HPV-16 & 18) infection by multiplex PCR (MPX-PCR) and its expression in oral sub mucous fibrosis and oral squamous cell carcinoma. Head Neck Oncol 5(1):4

20.

Kulkarni SS, Kulkarni SS, Vastrad PP et al (2011) Prevalence and distribution of high risk human papillomavirus (HPV) types 16 and 18 in carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev 12:645–648PubMed

21.

D’Souza G, Agrawal Y, Halpern J et al (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199:1263–1269CrossRefPubMedPubMedCentral

22.

Chung CH, Bagheri A, D’Souza G (2014) Epidemiology of oral human papillomavirus infection. Oral Oncol 50:364–369CrossRefPubMed

23.

Beachler DC, D’Souza G (2013) Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol 25:503–510CrossRefPubMedPubMedCentral

24.

Varnai AD, Bollmann M, Bankfalvi A et al (2009) The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept. J Oral Pathol Med 38:181–187CrossRefPubMed

25.

Garnaes E, Kiss K, Andersen L et al (2015) A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000–2010: the largest registry-based study to date. Int J Cancer 136:2196–2203CrossRefPubMed

26.

Koyama K, Uobe K, Tanaka A (2007) Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas. J Oral Pathol Med 36:18–24CrossRefPubMed

27.

Tural D, Eliçin O, Batur S et al (2013) Human papillomavirus is independent prognostic factor on outcome of oropharyngeal squamous cell carcinoma. Tumour Biol 34:3363–3369CrossRefPubMed

28.

Argiris A, Li S, Ghebremichael M, Egloff AM et al (2014) Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials. Ann Oncol 25:1410–1416CrossRefPubMedPubMedCentral

29.

Vainshtein JM, Spector ME, McHugh JB et al (2014) Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol 50:513–519CrossRefPubMedPubMedCentral

30.

Liang C, Marsit CJ, McClean MD et al (2012) Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res 72:5004–5013CrossRefPubMedPubMedCentral

31.

D’cruz AK, Yueh B, Das AK et al (2007) Validation of the University of Washington quality of life questionnaires for head and neck cancer patients in India. Indian J Cancer 44(4):147–154CrossRefPubMed

32.

Goon PK, Stanley MA, Ebmeyer J et al (2009) HPV & head and neck cancer: a descriptive update. Head & Neck Oncol 1:36CrossRef

33.

Madinier I, Doglio A, Cagnon L et al (1992) Southern blot detection of human papillomaviruses (HPVs) DNA sequences in gingival tissues. J Periodontol 63:667–673CrossRefPubMed

34.

Hormia M, Willberg J, Ruokonen H, Syrjanen S (2005) Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol 76:358–363CrossRefPubMed

35.

Tezal M (2012) Interaction between chronic inflammation and oral HPV infection in the etiology of head and neck cancers. Int J Otolaryngol 2012:575242CrossRefPubMedPubMedCentral

36.

Reuschenbach M, Kansy K, Garbe K et al (2013) Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. Oral Oncol 49:937–942CrossRefPubMed

37.

Lingen MW, Xiao W, Schmitt A et al (2013) Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 49:1–8CrossRefPubMed

38.

Duncan LD, Winkler M, Carlson ER et al (2013) p16 immunohistochemistry can be used to detect human papillomavirus in oral cavity squamous cell carcinoma. J Oral Maxillofac Surg 71:1367–1375CrossRefPubMed

39.

Walline HM, Komarck C, McHugh JB et al (2013) High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. JAMA otolaryngol– head Neck Surg 139:1320–1327CrossRefPubMedPubMedCentral

40.

Upile NS, Shaw RJ, Jones TM et al (2014) Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus related. Laryngoscope 124(12):2739–2744CrossRefPubMed

41.

van Houten VM, Snijders PJ, van den Brekel MW et al (2001) Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93:232–235CrossRefPubMed

42.

Wiest T, Schwarz E, Enders C et al (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21:1510–1517CrossRefPubMed

43.

Chau NG, Rabinowits G, Haddad RI (2014) Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options. Curr Treat Options in Oncol 15:595–610CrossRef

44.

Jamaly S, Khanehkenari MR, Rao R et al (2014) Relationship between p53 overexpression, human papillomavirus infection, and lifestyle in Indian patients with head and neck cancers. Tumour Biol 33:543–550CrossRef

45.

Mehta H, Nazzal K, Sadikot RT (2008) Cigarette smoking and innate immunity. Inflamm Res 57:497–503CrossRefPubMed

46.

HY O, Seo SS, Kim MK et al (2014) Synergistic effect of viral load and alcohol consumption on the risk of persistent high-risk human papillomavirusinfection. PLoS One 9:e104374CrossRef

47.

Schabath MB, Thompson ZJ, Egan KM et al (2015) Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in men (HIM) study. Sex Transm Infect 91(1):61–67CrossRefPubMed

48.

Kumar RV, Kadkol SS, Daniel R et al (2003) Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma. Int J Oral Maxillofac Surg 32:539–543CrossRefPubMed

49.

Chaturvedi AK (2012) Epidemiology and clinical aspects of HPV in head and neck cancers. Head and Neck Pathol 6:S16–S24CrossRef

50.

Olshan AF (ed) (2010) Epidemiology, pathogenesis, and prevention of head and neck cancer. Springer, New York

51.

Marur S, D’Souza G, Westra WH et al (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789CrossRefPubMed

52.

Chung CH, Gillison ML (2009) Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 15:6758–6762CrossRefPubMed

53.

Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269CrossRefPubMed

54.

Rischin D, Young RJ, Fisher R et al (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28:4142–4148CrossRefPubMedPubMedCentral

55.

Lassen P, Eriksen JG, Krogdahl A et al (2011) The influence of HPV associated p16 expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial. Radiother Oncol 100:49–55CrossRefPubMed

56.

Klussmann JP, Mooren JJ, Lehnen M et al (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15:1779–1786CrossRefPubMed

57.

Stransky N, Egloff AM, Tward AD et al (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333(6046):1157–1160CrossRefPubMedPubMedCentral

58.

Lindel K, Beer KT, Laissue J et al (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92:805–813CrossRefPubMed

59.

Sorensen BS, Busk M, Horsman MR et al (2014) Effect of radiation on cell proliferation and tumor hypoxia in HPV positive head and neck cancer in vivo models. Anticancer Res 34:6297–6304PubMed

60.

Won HS, Lee YS, Jeon EK et al (2014) Clinical outcome of induction chemotherapy in locally advanced head and neck squamous cell carcinoma. Anticancer Res 34:5709–5714PubMed

61.

Ang KK, Sturgis EM (2012) Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 22:128–142CrossRefPubMed

62.

Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720CrossRefPubMed

63.

Schwartz SR, Yueh B, McDougall JK et al (2001) Human papillomavirus infection and survival in oral squamous cell cancer: a population based study. Otolaryngol Head Neck Surg 125:1–9CrossRefPubMed

64.

Elango KJ, Suresh A, Erode EM et al (2011) Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev 12:889–896PubMed

65.

Kozomara R, Jovic N, Magic Z et al (2005) p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg 33:342–348CrossRefPubMed

66.

Duray A, Descamps G, Decaestecker C et al (2012) Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 122:1558–1565CrossRefPubMed

67.

Lee LA, Huang CG, Liao CT et al (2012) Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One 7:e40767CrossRefPubMedPubMedCentral

68.

Annertz K, Rosenquist K, Andersson G et al (2014) High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study. Acta Otolaryngol 134:843–851CrossRefPubMed

69.

Sharma A, Méndez E, Yueh B et al (2012) Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 146(5):739–745CrossRefPubMedPubMedCentral

70.

Maxwell JH, Mehta V, Wang H et al (2014) Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality. Laryngoscope 124(7):1592–1597CrossRefPubMed

Title: Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment—a Pilot Study from Northern India
Authors: Abhishek Kumar Singh
Jitendra Kumar Kushwaha
Akshay Anand
Abhinav Arun Sonkar
Nuzhat Husain
Kirti Srivastava
Sudhir Singh
Publication date: 01-12-2016
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 4/2016
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-016-0559-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment—a Pilot Study from Northern India

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

Deep Vein Thrombosis in Indian Cancer Patients Undergoing Major Thoracic and Abdomino-Pelvic Surgery

Comments on Radical Esophagectomy after Neoadjuvant Chemoradiation: Single Institutional Experience from Tertiary Cancer Centre in India

Evaluation of Surgical Outcomes of Oncoplasty Breast Surgery in Locally Advanced Breast Cancer and Comparison with Conventional Breast Conservation Surgery

Role of Axillary Ultrasound, Fine Needle Aspiration Cytology and Sentinel Lymph Node Biopsy in clinically N0 Breast Cancer

Extra Mammary Paget’s Disease of Vulva—a Case Report

Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer – a Single Centre Study. (PPLB – 01)